Free Trial
→ The Iran War Just Broke the Gold Market (From Behind the Markets) (Ad)tc pixel Free MD Stock Alerts

Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group logo
$22.24 +1.41 (+6.75%)
Closing price 03:59 PM Eastern
Extended Trading
$22.13 -0.11 (-0.48%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

MD vs. CHE, CRVL, AMN, CCRN, and DGX

Should you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Chemed (CHE), CorVel (CRVL), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Quest Diagnostics (DGX). These companies are all part of the "health care services" industry.

How does Pediatrix Medical Group compare to Chemed?

Pediatrix Medical Group (NYSE:MD) and Chemed (NYSE:CHE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Chemed has a net margin of 10.23% compared to Pediatrix Medical Group's net margin of 9.02%. Chemed's return on equity of 27.18% beat Pediatrix Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group9.02% 19.94% 8.02%
Chemed 10.23%27.18%17.38%

Pediatrix Medical Group currently has a consensus price target of $21.33, indicating a potential downside of 4.06%. Chemed has a consensus price target of $501.50, indicating a potential upside of 17.97%. Given Chemed's stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
Chemed
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Chemed has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B0.97$165.39M$1.9411.46
Chemed$2.53B2.23$265.24M$18.3523.17

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Pediatrix Medical Group has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500.

In the previous week, Chemed had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for Chemed and 9 mentions for Pediatrix Medical Group. Chemed's average media sentiment score of 0.89 beat Pediatrix Medical Group's score of 0.45 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Chemed
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Chemed beats Pediatrix Medical Group on 13 of the 15 factors compared between the two stocks.

How does Pediatrix Medical Group compare to CorVel?

Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 44.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Pediatrix Medical Group had 8 more articles in the media than CorVel. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 1 mentions for CorVel. Pediatrix Medical Group's average media sentiment score of 0.45 beat CorVel's score of 0.00 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CorVel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CorVel has a net margin of 11.23% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 30.15% beat Pediatrix Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group9.02% 19.94% 8.02%
CorVel 11.23%30.15%17.62%

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B0.97$165.39M$1.9411.46
CorVel$895.59M3.16$95.17M$2.0427.14

Pediatrix Medical Group presently has a consensus price target of $21.33, indicating a potential downside of 4.06%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, research analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
CorVel
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Pediatrix Medical Group has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, CorVel has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Summary

Pediatrix Medical Group and CorVel tied by winning 8 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to AMN Healthcare Services?

Pediatrix Medical Group (NYSE:MD) and AMN Healthcare Services (NYSE:AMN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Pediatrix Medical Group had 2 more articles in the media than AMN Healthcare Services. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 7 mentions for AMN Healthcare Services. Pediatrix Medical Group's average media sentiment score of 0.45 beat AMN Healthcare Services' score of 0.29 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AMN Healthcare Services
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pediatrix Medical Group has a net margin of 9.02% compared to AMN Healthcare Services' net margin of -3.51%. Pediatrix Medical Group's return on equity of 19.94% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group9.02% 19.94% 8.02%
AMN Healthcare Services -3.51%8.05%2.38%

Pediatrix Medical Group has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.91B0.97$165.39M$1.9411.46
AMN Healthcare Services$2.73B0.30-$95.70M-$2.49N/A

Pediatrix Medical Group presently has a consensus price target of $21.33, indicating a potential downside of 4.06%. AMN Healthcare Services has a consensus price target of $22.64, indicating a potential upside of 7.53%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29
AMN Healthcare Services
2 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.44

Pediatrix Medical Group has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500.

Summary

Pediatrix Medical Group beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Pediatrix Medical Group (NYSE:MD) are both small-cap health care services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Cross Country Healthcare presently has a consensus price target of $12.53, indicating a potential upside of 23.96%. Pediatrix Medical Group has a consensus price target of $21.33, indicating a potential downside of 4.06%. Given Cross Country Healthcare's stronger consensus rating and higher possible upside, equities analysts clearly believe Cross Country Healthcare is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

In the previous week, Pediatrix Medical Group had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 9 mentions for Pediatrix Medical Group and 6 mentions for Cross Country Healthcare. Pediatrix Medical Group's average media sentiment score of 0.45 beat Cross Country Healthcare's score of 0.07 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cross Country Healthcare has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

Pediatrix Medical Group has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.05B0.31-$94.85M-$2.93N/A
Pediatrix Medical Group$1.91B0.97$165.39M$1.9411.46

Pediatrix Medical Group has a net margin of 9.02% compared to Cross Country Healthcare's net margin of -9.00%. Pediatrix Medical Group's return on equity of 19.94% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-9.00% 0.13% 0.09%
Pediatrix Medical Group 9.02%19.94%8.02%

Summary

Pediatrix Medical Group beats Cross Country Healthcare on 12 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Quest Diagnostics presently has a consensus price target of $216.58, indicating a potential upside of 14.57%. Pediatrix Medical Group has a consensus price target of $21.33, indicating a potential downside of 4.06%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities analysts clearly believe Quest Diagnostics is more favorable than Pediatrix Medical Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50
Pediatrix Medical Group
0 Sell rating(s)
5 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.29

In the previous week, Quest Diagnostics had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 12 mentions for Quest Diagnostics and 9 mentions for Pediatrix Medical Group. Quest Diagnostics' average media sentiment score of 1.44 beat Pediatrix Medical Group's score of 0.45 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pediatrix Medical Group
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Quest Diagnostics has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

Quest Diagnostics has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$11.04B1.90$992M$9.0520.89
Pediatrix Medical Group$1.91B0.97$165.39M$1.9411.46

Quest Diagnostics has a net margin of 9.07% compared to Pediatrix Medical Group's net margin of 9.02%. Pediatrix Medical Group's return on equity of 19.94% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.07% 15.60% 7.06%
Pediatrix Medical Group 9.02%19.94%8.02%

Summary

Quest Diagnostics beats Pediatrix Medical Group on 11 of the 16 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MD vs. The Competition

Export
MetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.73B$8.11B$6.28B$22.97B
Dividend YieldN/A2.83%2.77%4.03%
P/E Ratio10.7915.9724.8425.50
Price / Sales0.9717.18491.7724.82
Price / Cash9.3281.3143.4225.32
Price / Book2.105.019.844.65
Net Income$165.39M$183.43M$3.55B$1.07B
7 Day Performance-0.34%2.51%3.90%2.66%
1 Month Performance2.53%4.62%6.04%7.00%
1 Year Performance53.24%3.01%40.49%32.62%

Pediatrix Medical Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MD
Pediatrix Medical Group
2.1515 of 5 stars		$22.24
+6.7%		$21.33
-4.1%		+61.2%$1.73B$1.91B10.794,315
CHE
Chemed
4.8578 of 5 stars		$427.80
+1.2%		$501.50
+17.2%		-25.7%$6.26B$2.53B23.3515,811
CRVL
CorVel
0.3507 of 5 stars		$58.22
+0.2%		N/A-48.4%$2.97B$941.49M28.495,075
AMN
AMN Healthcare Services
2.1553 of 5 stars		$21.34
+1.7%		$22.64
+6.1%		+6.6%$827.34M$2.73BN/A2,664
CCRN
Cross Country Healthcare
3.0208 of 5 stars		$10.38
+0.8%		$12.53
+20.7%		-21.0%$333.42M$1.05BN/A6,784

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:MD) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
One executive order. The biggest wealth transfer of your lifetime.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
BlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?
BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...
Awesomely, LLC | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel